Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Multiple product indications withdrawn, FDA accelerated Approval How to reform? >> article
 
Multiple product indications withdrawn, FDA accelerated Approval How to reform?
Editor:xuezhe     Clicks:0    Date:2023-4-20 14:32:18
Keyword: FDA
Healthoo Information:
Multiple product indications withdrawn, FDA accelerated Approval How to reform?
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Tronsound long-acting IL-36R antibody obtained FDA clinical IND
  • Tronsound long-acting IL-36R antibody obtained FDA clinical IND
  • 2022 FDA approval of new drug transcript
  • The first in the world! Huadong Pharmaceuticals new FRα target ADC was...
  • FDA Success Stories CDE Recommendations: How MIDD Accelerates Drug Dis...
  • The worlds first Upadatinib extended-release tablets approved by FDA f...
  • Sodium thiosulfate has been approved by the FDA to reduce hearing loss...
  • FDA approves ibrutinib for chronic graft-versus-host disease in childr...
  • FDA Issues Drug Statement, Mercks Hypoglycemic Drug Sitagliptin Detect...
  • Upadatinibs launch accelerated: Crohns disease has simultaneously subm...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map